Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; a7-nAChR; alpha7-nicotinic acetylcholine receptor; Ang II; angiotensin II; AP; area postrema; AR; adrenergic receptor; AT1R; angiotensin type 1 receptor; AT2R; angiotensin type 2 receptor; AV3V; anteroventral third ventricle; BBB; blood-brain barrier; CNS
مقالات ISI پراکسیزوم پرولیفراتور فعال گیرنده گاما (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; AT; adipose tissue; LPS; lipopolysaccharide; OSA; obstructive sleep apnea; PPARγ; peroxisome proliferator-activated receptor-gamma; PTP-1B; protein tyrosine phosphatase 1B; Obstructive sleep apnea adipose tissue; Insulin resistance; Macrophage; Epigeneti
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; AMPKα2; AMP-activated protein kinase α2; CT; computerized tomography; CI; confidence interval; EPIC-Norfolk; European Investigation into Cancer; HbA1c; higher hemoglobin A1c; HOMA-β; homeostatic model assessment method; MKP1; MAP kinase phosphatase-1;
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Adr; Adriamycin; miRNA; microRNA; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; mRNA; messenger RNA; RT-qPCR; real-time quantitative PCR; KEGG; Kyoto Encyclopedia of Genes and Genomes; PPI; protein-protein interaction; CHOL; cholest
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; BMD; bone mineral density; BMSC; Bone marrow stromal cell; Col1a1; collagen type 1 alpha-1; CTSK; cathepsin K; CTx; cross-linked type I collagen; HDL; high density lipoprotein; HFD; high-fat diet; LDL; low density lipoprotein; LDLRâ/â; Low-density lip
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; AGE; advanced glycation end product; aBMD; areal bone mineral density; BMD; bone mineral density; BMI; body mass index; DPP-4; dipeptidyl peptidase-4; DXA; dual-energy X-ray absorptiometry; eBMD; estimated bone mineral density; GLP-1; glucagon-like peptid
Oral administration of palatinose vs sucrose improves hyperglycemia in normal C57BL/6J mice
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Palatinose; Hepatic lipogenesis; Cholesterol homeostasis; C57BL/6J mice; Sucrose; ACC; acetyl-CoA carboxylase; ALT; alanine aminotransferase; AST; serum aspartate aminotransferase; AUC; area under the curve; CYP7A1; cholesterol 7 alpha-hydroxylase; FAS; f
The ADRA2A rs553668 variant is associated with type 2 diabetes and five variants were associated at nominal significance levels in a population-based case-control study from Mexico City
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; ADRA2A; Alpha-2a-adrenergic receptor; BMI; Body mass index; CHO; Cholesterol; DNA; Deoxyribonucleic acid; ENSANUT; National Survey of Health and Nutrition; FPG; Fasting plasma glucose; GWAS; Genome wide association study; HDL-C; Cholesterol high density l
Oral vitamin-A-coupled valsartan nanomedicine: High hepatic stellate cell receptors accessibility and prolonged enterohepatic residence
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Targeted valsartan-therapy; Vitamin-A-coupled liposomes; Peroxisome proliferator-activated receptor-gamma; Stellate cells; Mas-receptor;
High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; CKD; chronic kidney disease; PPARγ; peroxisome proliferator-activated receptor-gamma; VMSCs; mouse vascular smooth muscle cells; Mecp2; methyl-CpG binding protein 2; Runx2; runt-related transcription factor 2; BMP-2; bone morphogenic proteins-2; BUN; blo
Orally administered berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-γ and subsequent expression of HGF in colons
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Berberine; Pulmonary fibrosis; Gut; HGF; PPAR-γ; aP2; adipocyte fatty acid-binding protein 2; BMP-7; bone morphogenetic protein-7; BPV; a PTEN inhibitor; CD36; cluster of differentiation 36; ECM; extracellular matrix; EMSA; electrophoretic mobility shift
Protective roles of fenofibrate against cisplatin-induced ototoxicity by the rescue of peroxisomal and mitochondrial dysfunction
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Cisplatin; Fenofibrate; NADPH Oxidase Isoforms; PPAR-α; Ototoxicity; ABR; auditory brainstem responses; ACOX1; peroxisome acyl-coenzyme A oxidase 1; ARF; acute renal failure; AKI; acute kidney injury; B-FABP; brain-type fatty acid binding protein; COX5A1
d-Psicose, a sugar substitute, suppresses body fat deposition by altering networks of inflammatory response and lipid metabolism in C57BL/6J-ob/ob mice
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Abcd2; ATP-binding cassette, sub-family D, member 2; aP2; adipocyte protein 2; C/EBP-α; CCAAT/enhancer-binding protein-alpha; CPT-1; carnitine palmitoyltransferase-1; FAS; fatty acid synthase; FC; fold change; Fgf21; fibroblast growth factor 21; Fos; FBJ
Leptin in congenital and HIV-associated lipodystrophy
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; POMC; pro-opiomelanocortin; NPY; neuropeptide Y; MRI; magnetic resonance imaging; AMPK; adenosine monophosphate-activated protein kinase; HIV; Human Immunodeficiency Virus; HALS; HIV-associated lipodystrophy syndrome; CT; computed tomography; DEXA; dual-e
Retinaldehyde dehydrogenase 1 deficiency inhibits PPARγ-mediated bone loss and marrow adiposity
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Aldh1a1; retinaldehyde dehydrogenase 1; AA; Ascorbic acid; ALP; alkaline phosphatase; AR; alizarin red; BGP; beta glycerol phosphate; BMP2; bone morphogenetic protein 2; CSF; colony stimulating factor; HFD; high fat diet; HSC; hematopoietic stem cell; MSC
The role of methyl-CpG binding protein 2 in liver fibrosis
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; HSC; hepatic stellate cell; ECMs; extracellular matrices; α-SMA; α-smooth muscle actin; TGF-β; transforming growth factor-β; TRD; Transcriptional Repression Domain; CTD; C-Terminal Domain; PPARγ; peroxisome proliferator-activated receptor-gamma; PDGF
Adipokines in the HIV/HAART-associated lipodystrophy syndrome
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; HAART; highly active antiretroviral therapy; HALS; HIV/HAART-associated lipodystrophy syndrome; PPAR-gamma; peroxisome proliferator-activated receptor-gamma; IL-6; interleukin-6; TNF-α; tumor necrosis factor-alpha; IGF-1; insulin-like growth factor 1; Le
Arsenic inhibits the adipogenic differentiation of mesenchymal stem cells by down-regulating peroxisome proliferator-activated receptor gamma and CCAAT enhancer-binding proteins
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; MSCs; mesenchymal stem cells; PPARγ; peroxisome proliferator-activated receptor-gamma; C/EBPs; CCAAT/enhancer-binding proteins; iAsIII; arsenite; ORO; Oil Red O staining; Mesenchymal stem cells; Arsenic; Adipogenesis; Differentiation; PPAR-γ; C/EBP fami
Differentiation and gene expression profile of tumor-associated macrophages
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; TAM; tumor-associated macrophage; M1; classically activated macrophages; M2; alternatively activated macrophages; iNOS; inducible nitric oxide synthetase; RUNX1; runt-related transcription factor 1; NF-κB; nuclear factor kappaB; IRF8; interferon regulato
Ethanolic extract of seabuckthorn (Hippophae rhamnoides L) prevents high-fat diet-induced obesity in mice through down-regulation of adipogenic and lipogenic gene expression
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Hippophae rhamnoides L.; Seabuckthorn; Obesity; Leptin; Lipid metabolism; Fatty liver; Mice; ACC; Acetyl-CoA Carboxylase; CPT-1; Carnitine palmitoyltransferase-1; HD; High-fat diet; HDL-C; High-density lipoprotein- cholesterol; ND; Normal diet; OGTT; Oral
Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; CXCL9; CXCL10; Chronic autoimmune thyroiditis; Hypothyroidism; Chemokines; IFN; interferon; MIG; monokine induced by IFN-γ; CXCL; chemokine (CXC motif) ligand; IP-10; IFN-g-induced protein 10 kDa; I-TAC; IFN-inducible T cell α chemoattractant; CXCR; CXC
Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; 4E-BP1; 4E binding protein 1; 5â²UTR; 5â² untranslated region; AICAR; 5-aminoimidazole-4-carboxamide riboside; AMP; adenosine monophosphate; AMPK; 5â²-AMP-activated protein kinase; AMPK α1â/â; AMPK α1 subunit knockout; AMPKα1â/âα2â/â; A
Association of peroxisome proliferator-activated receptor-gamma gene polymorphisms with the development of asthma
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Peroxisome proliferator-activated receptor-gamma; Asthma; Gene; Single nucleotide polymorphism
Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Nuclear hormone receptors; Peroxisome proliferator-activated receptor-gamma; Immunohistochemistry; First trimester; Normal pregnancy; Miscarriage
PPARG Pro12Ala genotype and risk of cognitive decline in elders? Maybe with diabetes
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Peroxisome proliferator-activated receptor-gamma; Pro12Ala PPARG; Cognitive ageing; IQ; Cognitive function
Efectos metabólicos del tratamiento con antagonistas de los receptores de la angiotensina II
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Antagonistas de los receptores de angiotensina II; Efectos metabólicos; Receptores PPARγ; Prevención de diabetes mellitus; Síndrome metabólicoAngiotensin-II receptor antagonist; Metabolic effects; Peroxisome proliferator-activated receptor-gamma; Diabetes
Quantification of PPAR-γ protein in monocyte/macrophages from healthy smokers and non-smokers: A possible direct effect of nicotine
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Peroxisome Proliferator-Activated Receptor-gamma; Monocytes; Monocyte-derived macrophages; Tobacco smoke; Nicotine; Tumour Necrosis Factor-alpha; Interleukin-6; Ciglitazone; PPAR-γ ligands;
Circulating Concentrations of Adiponectin, an Endogenous Lipopolysaccharide Neutralizing Protein, Decrease in Rats with Polymicrobial Sepsis
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; adiponectin; lipopolysaccharide; metabolic syndrome; tumor necrosis factor-alpha; sepsis; cecal ligation and puncture; peroxisome proliferator-activated receptor-gamma; proinflammatory cytokine
Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Peroxisome proliferator-activated receptor-gamma; Obesity; Insulin resistance; Free fatty acids; Cytokines; thiazolidinedioneAcrp30, adipocyte complement-related protein of 30 kDa; CHF, congestive heart failure; DBD, DNA-binding domain; FFA, free fatty ac
Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; Inflammation; Peroxisome proliferator-activated receptor-gamma; Amyotrophic lateral sclerosis;
Effect of thiazolidinediones on equilibrative nucleoside transporter-1 in human aortic smooth muscle cells
Keywords: پراکسیزوم پرولیفراتور فعال گیرنده گاما; ENT; equilibrative nucleoside transporter; HASMCs; human aortic smooth muscle cells; NBMPR; nitrobenzylmercaptopurine riboside; PPARγ; peroxisome proliferator-activated receptor-gamma; Thiazolidinediones; Troglitazone; Adenosine; Diabetes; Nucleoside tra